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Ribonuclease A has been used as a  model protein for 
studying the  specificity of glycation of amino groups 
in protein under physiological conditions (phosphate 
buffer, pH 7.4, 37 “C). Incubation  of RNase with  glu- 
cose led to an enhanced rate of inactivation of the 
enzyme relative to the rate of modification of lysine 
residues, suggesting preferential modification of active 
site  lysine residues. Sites of glycation of RNase were 
identified by amino acid analysis of tryptic peptides 
isolated by reverse-phase high pressure liquid chro- 
matography and phenylboronate affinity chromatog- 
raphy. Schiff base adducts were trapped with Na- 
BH&N and the a-amino group  of Lys-1  was identified 
as the primary site (80-90%) of initial Schiff base 
formation on RNase. In contrast, Lys-41 and Lys-7 in 
the  active  site accounted for about 38 and 29%, respec- 
tively, of ketoamine adducts formed via the Amadori 
rearrangement. Other sites  reactive  in ketoamine for- 
mation included Ne-Lys-1 (15%), N-Lys-1 (9%), and 
Lys-37 (9%) which  are adjacent to acidic amino acids. 
The remaining six lysine residues in RNase, which are 
located on the surface of the protein, were  relatively 
inactive in forming either the Schiff base or  Amadori 
adduct. Both the equilibrium Schiff base concentration 
and the rate of the Amadori rearrangement at each site 
were found to be important in determining the speci- 
ficity of glycation of RNase. 
Glycation or nonenzymatic glycosylation of protein occurs 
as  the result of a reaction between reducing sugars and  the 
primary amino groups on protein. The initial product is a 
labile Schiff base derivative of the protein which  slowly 
isomerizes to  the more stable ketoamine adduct via the Ama- 
dori rearrangement (Fig. 1) (1-3). Although formation of 
Schiff bases is known to depend on the pKa (nucleophilicity) 
of amino groups, much less is known about factors which 
promote the formation of the Amadori product at specific 
amino groups in protein. Glycation takes place at t-amino 
groups of lysine or hydroxylysine residues as well as at a- 
amino groups of amino-terminal residues (3). The /3-chain 
terminal valine residue has been identified as a highly reactive 
site in hemoglobin (3 ,4)  and specific lysine residues in hemo- 
globin (5) and human serum albumin (6) have also been 
identified as  preferential  sites of glycation of these  proteins 
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in uiuo. In hemoglobin, the most reactive lysine residues 
appeared to be located adjacent to carboxylate groups in the 
primary or three-dimensional structure of the protein (5), 
while in albumin the reactive lysine is adjacent to another 
lysine residue in the primary sequence (6). With these excep- 
tions, however, there is little information regarding specificity 
in glycation of protein. 
In previous work, we had obtained evidence for a range in 
rates of glycation of lysine residues in bovine pancreatic 
RNase’ (7) and we expected that  further study of the reactiv- 
ity of lysine residues in this  protein would help in  understand- 
ing the specificity in modification of other  proteins by glucose. 
RNase (Fig. 2) (8,9) contains 10 lysine residues including the 
amino-terminal residue, for a total of 11 primary amino 
groups. Two amino groups have low pK, values, N”-Lys-l 
with pKa - 7.8 and  w-Lys-41 with pKa - 8.8 (8), making 
them potentially more reactive in formation of the Schiff 
base, while the remainder of the lysine amino groups with 
pK, - 10.5 should be less reactive. Three lysines (1, 7, and 
41) are  in or near the active site  and modification of any one 
of these three  has been shown to decrease the specific enzy- 
matic activity of RNase (8-10). In  this  paper, we compare the 
sites of formation of Schiff base and Amadori adducts to 
RNase and describe factors which affect the specificity of 
glycation of amino groups in this  protein. 
EXPERIMENTAL  PROCEDURES 
Materials-Bovine pancreatic RNase A (Type  XII-B), tosylphen- 
ylalanyl chloromethyl ketone-treated  trypsin (Type XIII), yeast 
RNA, sodium borohydride, and sodium cyanoborohydride were ob- 
tained from Sigma. Affi-Gel 601 (phenylboronate affinity resin) was 
purchased from Bio-Rad and P-D-glucose from P-L Biochemicals. 
NaB[3H]4 and  ~-[6-~H]glucose were purchased from New England 
Nuclear. Radioactive glucose  was purified (11) by column chromatog- 
raphy using Dowex 50W-X8 in the Ca2+ form (12). The glucose  was 
eluted with deionized water, concentrated to dryness by rotary evap- 
oration, dissolved in incubation buffer, and normally used within 24 
h of preparation. 
Reaction of RNase with  Glucose-RNase (25 mg/ml) was incubated 
with 0.4 M glucose in 0.1 M sodium phosphate buffer, pH 7.4 at 37 “C. 
The concentration of native RNase in solution was determined by 
measuring absorbance at 280 nm (El% = 7.1) (8). RNase enzymatic 
activity was measured using yeast RNA as substrate (13). The actual 
glucose concentration  in the incubation was measured by the glucose 
oxidase-peroxidase assay (Amresco). Reaction mixtures were filtered 
through 0.2 filters (Gelman)  into sterile microfuge tubes to prevent 
bacterial contamination. Aliquots were  removed under sterile condi- 
tions at desired times and frozen at -20 “C until assayed. 
Reduction of Ketoamine Adducts-Prior to reduction of glycated 
protein, samples (typically 5 mg RNase) were diluted to 1 ml with 0.2 
M sodium acetate, pH 5, and incubated at 37 “C for 2 h to discharge 
glycosylamine adducts (14). The pH  5-treated protein was then di- 
The abbreviations used are: RNase, bovine pancreatic ribonu- 
clease A RP-HPLC, reverse-phase high pressure liquid chromatog- 
raphy. 
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FIG. 1. Pathway for glycation of protein. The Schiff base 
intermediate and  the ketoamine (Amadori compound) exist primarily 
in cyclic furanose and pyranose conformations (2). The Schiff base 
adduct  can be trapped by reduction with cyanoborohydride to Ne- 
glucitollysine, while the ketoamine is reduced by borohydride to a 
mixture of N'-glucitol- and N'-mannitollysine. 
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FIG. 2. Sequence of amino acids (8) and sites of trypsin 
cleavage (9) of RNase. 
alyzed overnight against  4  liters of  0.1 M sodium phosphate,  pH 7.4, 
at 4 "C to remove  glucose. The dialyzed protein was reduced by adding 
a 50-fold molar excess of NaB[3HJr (70 pCi/gmol) in 0.1 M NaOH. 
The pH of the solution was estimated using narrow range pH paper 
and adjusted as required to  pH 8-9 with 1 N NaOH. After 4  h a t  room 
temperature, the reaction was terminated by the slow addition of 1 N 
HCI to destroy excess NaBH4. The samples were then dialyzed 
overnight at 4 "C against  4 liters of distilled water. 
Determination of the Extent of Modification of RNase-An aliquot 
of reduced RNase was diluted with an equal volume of 12 N HCl and 
hydrolyzed at 110 "C for 24 h. The sample was then analyzed on a 
Beckman Model 119C amino acid analyzer. The extent of lysine 
modification was calculated by comparing the 1ysine:alanine ratio in 
glycated uersus native RNase, using the alanine in RNase as an 
internal  standard. 
Quuntitation of the Ratio of Nm- to N'-Hexitollysine-Aliquots of 
NaB[3H]r-reduced glycated protein or peptides were hydrolyzed in 6 
N HCI at 95 "C for 18 h. These hydrolysis conditions do not yield 
quantitative hydrolysis of all peptide bonds in RNase, but do yield 
quantitative recovery of lysine with minimal degradation of hexitol- 
lysines (15). The radioactive hydrolysates were chromatographed on 
a cation exchange column using a  Waters HPLC amino acid analyzer. 
To optimize separation of the lysine derivatives, a complex gradient 
was generated from two buffers (A: 0.2 N Na' citrate,  pH 3.5;  B: 0.8 
N NaCl in 0.2 N Naf  citrate, pH 7.4; initial conditions: flow rate 0.5 
ml/min, 100% A; 50 min, 30% A, linear gradient (Waters Curve 6); 
60 min, 0% A, convex gradient (Waters curve 8); 80 min, 0% A. 
Fractions (3-5 drops) were collected directly into 5-ml scintillation 
vials and counted in Budget-Soh scintillation fluid (Research Prod- 
ucts International). The radioactive peaks were identified by com- 
parison to N"- and Ne-glucitollysine and Nu- and N'-mannitol lysine 
standards synthesized as described previously (7). 
Peptide Mapping of RNase-Reduced RNase was treated with 
performic acid (X), evaporated to dryness, and then resuspended in 
0.1 M sodium phosphate, pH 8.0. Trypsin (0.1% w/w) was added and, 
after  a 24-h digestion at 37 "C, was inactivated by adjusting to pH 2 
with 1 N HCl. The samples were frozen at -20 "C until analyzed. 
Peptides were separated on a Beckman ODS ultrasphere (reverse- 
phase) column using a Varian 5020 HPLC. A water-acetonitrile 
gradient was  developed, based on that previously reported by Black- 
burn  et al. (17, 18). Buffer A consisted of 0.1% trifluoroacetic acid 
(Sequanal grade, Pierce) in distilled water and Buffer B was 0.1% 
trifluoroacetic acid in 50% acetonitrile (HPLC grade, Burdick and 
Jackson). The column was equilibrated with 4% buffer B at 1 ml/ 
min and  the peptides eluted with a combination of isocratic and linear 
gradient steps. The program was as follows: 0 min, 4% buffer B; 5 
min, 4% B; 25 min, 20% B;  45 min, 20% B;  75 min, 40% B;  95 min, 
65% B;  100 min, 65% B;  115 min, 70% B. Peptides were detected by 
their absorbance at 214 nm and the various peak fractions were 
pooled, dried under nitrogen, and characterized by amino acid anal- 
ysis. The order of elution of peptides (shown in Fig. 6A)  was identical 
with that previously reported by Blackburn et al.  (17, 18). Glycated 
peptides, labeled either with radioactive glucose or by reduction with 
NaB[3H]r, were located by assaying aliquots of column fractions for 
radioactivity. 
Characterization of Glycated Peptides-Separation of glycated from 
unmodified peptides was achieved by affinity chromatography using 
phenylboronic acid resin which selectively binds vicinal diols of the 
reduced  glucose residue in glycatedpeptides. The radioactive fractions 
eluted from the reverse-phase column were  pooled, evaporated under 
nitrogen, and redissolved in 0.5 ml of 0.025 M sodium phosphate, pH 
8.5. The sample was applied to a 2-ml affinity column, equilibrated 
with 20 ml of 0.025 M sodium phosphate, pH 8.5. The column was 
washed with 5 ml  of starting buffer and  the bound glycated peptides 
eluted with 7 ml of 50 mM acetic acid. Aliquots (0.1 ml) of each 
fraction (1 ml) were counted, radioactive peaks were pooled, and 
peptides were identified by amino acid composition. 
RESULTS 
Kinetics of Modification of RNase by Glucose-RNase  was 
incubated with glucose in order to study both its rate of 
reaction with glucose and  the effect of glycation on its enzy- 
matic activity. In earlier studies (7), we had observed that  the 
rate of glycation of RNase in uitro was first  order in glucose 
concentration up to  at least 1 M glucose. The present  studies 
were done at 0.4 M glucose for convenience, in order to yield 
protein with about 1 mol  of Glc/mol of RNase within 3 days 
at physiological temperature  and  pH. The kinetics of glycation 
and loss of enzymatic activity are shown in Fig. 3. The initial 
rate of glycation was approximately 12% lysine modification. 
mol&ase. day"; however, the  rate of modification was 
nonlinear on the semilog plot, indicating that not  all lysines 
were reacting at  the same rate. In addition, the initial  rate of 
loss of enzymatic activity was 42% inactivation + M&. day", 
i.e. about 3.5 times the rate of modification of lysine residues. 
The enhanced  rate of inactivation of the enzyme compared to 
the  rate of lysine modification suggested that glycation, ie .  
formation of the Amadori adduct, was occurring preferentially 
at active site lysine residues. 
When  the glycation reaction is carried out  in the presence 
of NaBH3CN, this reagent traps  the Schiff base intermediate 
by reducing it directly to glucitollysine (Fig. 1). Proteins are 
modified  more rapidly in this case because the rate of forma- 
tion and reduction of the Schiff base is more rapid than  that 
of the Amadori rearrangement (1, 3). As shown in Fig. 4, the 
initial  rate of modification of RNase by glucose in  the presence 
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FIG. 3. Kinetics of glycation and inactivation of RNase by 
glucose. RNase (25 mg/ml) was incubated in 0.4 M glucose in 0.1 M 
sodium phosphate, pH 7.4, at  37 "C. The extent of glycation was 
determined from the loss of lysine residues as determined by amino 
acid analysis. The loss of enzymatic activity in  control incubations 
in buffer without glucose was less than 10% at 25 days. 
of a large excess of NaBH3CN is  about 12% lysine modifica- 
tion. mol&,, . M&. h-', i.e. more than 20 times  faster than  the 
rate of the Amadori rearrangement (Fig. 3). The  rate of loss 
of enzyme activity was 14% inactivation. M&. h-'. Thus,  dur- 
ing the early stages of the reaction in  the presence of Na- 
BH3CN, before extensive modification of the protein had 
occurred, the rates of modification of lysine residues and loss 
of enzymatic activity were similar. In Fig. 5, the loss of lysine 
residues is compared to the loss of enzymatic activity for 
protein modified by glucose in the presence and absence of 
NaBH3CN. In the presence of NaBH3CN, 15% of the enzy- 
matic activity is lost when 20% of the lysine residues are 
modified; while in  the incubation without the reducing re- 
agent, 65% of the activity is lost at  the same degree of glucose 
modification. These data suggest not only that there are 
differences in the sites of modification of RNase in the pres- 
ence and absence of NaBH3CN, but also that,  in comparison 
to Schiff base formation, glycation of RNase occurs prefer- 
entially at active site lysine residues. 
Initial Sites of Formation of Amadori  Adducts to RNase- 
The sites of modification of RNase by glucose  were examined 
by tryptic peptide analysis of RNase modified with 1 mol of 
Glc/mol of protein, i.e. after 3 days incubation with glucose 
(Fig. 3). In the initial experiments, the peptides were labeled 
by reaction of RNase with 6-[3H]glucose, followed  by reduc- 
tion with NaBH4. An alternate  and less expensive method of 
labeling the glycated peptide was also evaluated, i.e. 
NaB[3H]4 reduction of RNase modified with unlabeled glu- 
cose. Despite potential problems from nonspecific reduction 
of cystine and peptide bonds by NaB[3H]4 (19), the two 
labeling methods yielded identical radioactive peptide profiles 
on RP-HPLC (Fig. 6), so long as  the reduction reaction was 
pap 
~~ ~ ~ ~ ~~ 
0 16 24 
TIME (hours) 
FIG. 4. Kinetics of glycation and inactivation of RNase by 
glucose in the presence of NaBHsCN. RNase was reacted with 
glucose as described in Fig. 3 except that  the incubation also contained 
0.4 M NaBHSCN. No loss of enzymatic activity was observed in 
control incubations of RNase with NaBH3CN (without glucose) after 
24 h. 
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FIG. 5. Comparative loss of RNase enzymatic activity uer- 
sus lysine modification by glucose in the presence and absence 
of NaBH&N. 
maintained at  pH 8-9. Higher pH  during the NaB[3H]4 re- 
duction yielded increased incorporation of radioactivity into 
the protein and a more complex peptide map, resulting in 
part from incomplete digestion of the protein. Since the 
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FIG. 6. Comparison of tryptic peptide maps obtained by RP- 
HPLC. A, peptide map of native RNase. Peptides are numbered as 
shown in Fig. 2. B, radioactive peptide map of RNase glycated with 
6 - [ 3 H ] g l ~ ~ ~ ~ e ,  followed by reduction with NaBH4. The modified ly- 
sine residue is identified in each peak. C, radioactive peptide map of 
RNase glycated with nonradioactive glucose, then reduced with 
NaB[3H]4. 
results of the two procedures were identical, further  charac- 
terization of glycated peptides was done using NaB['HJ4- 
reduced protein. To identify the peptides, radioactive peaks 
were  pooled from the reverse-phase column and  the glycated 
peptides were isolated by affinity chromatography on phen- 
ylboronic acid resin (Fig. 7) and identified by amino acid 
analysis (Table I). 
The first peak, which eluted from the  RP-HPLC column at 
21 min and contained approximately 24% of the  total peptide 
radioactivity, was identified as glycated T1, containing lysine 
residues 1 and 7 (Table 11). This peptide was not resolved 
from the unmodified peptide in  our chromatographic system 
and, since glycation of Lys-7 would have blocked tryptic 
cleavage at  that site  (5),  Lys-1  must be the site of modification. 
To determine whether the  a- or c-amino group was  modified, 
aliquots of both  total  protein  and glycated peptide TI were 
hydrolyzed and  the N"- and N'-hexitollysine derivatives were 
separated by ion exchange HPLC (Fig. 8). The radioactivity 
profile from the total  protein (Fig. 8A) indicated a distribution 
of 17a N"- and 83% N'-modification of the protein, compared 
to a distribution of 61% Nu- and 39% N'-modification of 
glycated peptide Tl (Fig. 8B). A trailing peak at 22-23 min 
was consistently observed in the chromatograms (see Fig. 9 
and discussion below) and was identical with TI by amino 
acid composition and  the ratio of a- to c-amino group modi- 
fication. This peak was included in the  total of 24% glycated 
T, (Table 11). The estimate of a-amino group glycation of the 
total  protein  (17%, Fig. 8A) was in good agreement with the 
estimate of 15% a-modification based on 61% a-modification 
of peptide T, (Fig. 8B) which accounted for 24% of glycated 
peptides. 
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FIG. 7. Isolation of glycated peptides by affinity chromatog- 
raphy on phenylboronate resin (Table I). A, peptide TI contain- 
ing glycated Lys-1. B, peptide TW containing glycated Lys-37. C, 
peptide T1, containing glycated Lys-7. D, peptide T,* containing 
glycated Lys-41. 
The second peak of radioactivity, eluting from the RP- 
HPLC column at 36 min, contained 9% of the total radioac- 
tivity  (Table 11). This peptide was identified as TE4, residues 
34-39 (Table I), containing Lys-37. The glycated peptide 
eluted approximately 9 min later than the native peptide 
which contains Lys-37 (T5, residues 34-37, at 27 min). 
The  third peak at 73 min contained 29% of total radioac- 
tivity and was identified as  containing residues 1-10. 
This peptide contains 2 lysine residues (1 and 7), with Lys-7 
being  modified.  Amino acid analysis of aliquots taken from 
across the peak were identical indicating that even though 
the peak appeared heterogeneous by RP-HPLC, it was essen- 
tially homogeneous in amino acid composition. As indicated 
above, a  satellite peptide was also observed following peptide 
T1 and was indistinguishable from T1 by amino acid analysis. 
Some heterogeneity was also observed for many of the pep- 
tides in the native protein (Fig. 6A), suggesting that these 
peaks were probably artifacts or ghost peaks generated by 
nonuniform sample loading or transport on the  HPLC col- 
umn. The fourth peak at 97 min, with 38% of total radioac- 
tivity, contained  the most reactive site of glycation of RNase. 
This peptide was unusual because typically only about 35% 
of the applied radioactivity was retained on the phenylboronic 
acid affinity column (Fig. 70). This behavior was reproducible 
and a fraction of the unbound peptide would bind to the 
phenylboronic acid  column  on reapplication. Similar results 
were obtained with this peptide prepared from incubations of 
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TABLE I , 
Identification of glycated peptides by amino acid analysis 
Peptide identification 
Amino acidb TI (21)" Tw(36)  TI-2 (73) TM (97) 
Observed Theoretical Observed Theoretical Observed Theoretical Observed Theoretical 
Asx 2.1 2 0.5 2.0 2 
Thr 1.2 1 1.1 1 1.5 1 0.8 1 
Ser 1.9 2 
Glx 1.1 1 0.5 2.1 2 2.1 3 
G ~ Y  0.7 
Ala 3.O* 3 0.5 3.0: 3 2.0* 2 
Val 
Ile 
Leu 1.0* 1 0.8 1 
TY r 
Phe 1.0 1 0.8 1 
His 0.8 1 
Lys' 1.0 2 0.3 1 1.1 2 1.0 2 
Arg 1.0 1 0.9 1 0.2 
Numbers in parentheses  represent  retention time in minutes. 
Amino acid composition is based on asterisked residue, alanine  or leucine. 
"Hexitollysine was not quantitated. Observed lysine content should be one less than theoretical for run-on 
peptides. 
TABLE I1 
Distribution of dycated  mptides  in RNase 
% radioactivity" 
21 TI 1 24d 82' 66 
36 T6-4 37 9 3 7  
73 TI-z 7 29 6 14 
97 T7-8 41 38 9 14 
Per cent of total radioactivity in peptides. The fraction of radio- 
activity at  the void volume (3 min) was variable (5-10%). Analysis of 
this fraction from several different column runs indicated that  it did 
not contain hexitollysines. 
RNase glycated with unlabeled glucose (1 mol/mol), then reduced 
with NaB[3H]4. 
e RNase reacted with [6-3H]glucose in the presence of NaHB3CN. 
Columns A and B  represent protein labeled with 0.6 and 1.5 mol of 
Glc/mol of RNase, respectively. 
N":N"hexitollysine = 61:39 (Fig. 8). 
e N":N"hexitollysine = 86:14 (Fig. 1OA). 
RNase with 6-[3H]glucose and NaBH3CN (see below). Both 
the bound and unbound peptides could be identified as  tryptic 
peptide T7-8  containing residues 40-61. This peptide has two 
lysine residues (41 and 61) and, because it co-elutes with 
native T7-8, Lys-41 must be the site of glycation. This is a 
large, relatively hydrophobic peptide and  its binding to  the 
phenylboronic acid column may  be inhibited by tertiary  struc- 
ture in the peptide. 
The overall results of the peptide mapping indicate that 
lysines 1, 7,  37, and 41 are  the most reactive sites for modifi- 
cation of RNase by glucose. The high reactivity of lysines 7 
and 41 which are in the active site  and of lysines 1 and 37 
which neighbor the active site cleft is consistent with the 
earlier suggestion that  the rate of inactivation of RNase by 
glucose indicated preferential modification of active site res- 
idues. 
Sites of Formation of Schiff Base Adducts to RNase-To 
determine if the same lysine residues in RNase were equally 
reactive in formation of both Schiff base and Amadori ad- 
ducts, the Schiff base adducts were trapped by glycation of 
RNase with 6-[3H]glucose in the presence of NaBH3CN.  Two 
separate incubations were conducted for 15 and 30 min, 
respectively. The reactions were quenched by adjusting to  pH 
4 with acetic acid, then quickly chromatographed on Sephadex 
G-25 at 4 "C. This yielded preparations of RNase containing 
0.6 and 1.5 mol of Glc/mol of protein. Peptide analysis by 
RP-HPLC indicated that  the most reactive amino acid  was 
Lys-1 accounting for about 82 and 66% of all lysine modifi- 
cation in the protein at 0.6 and 1.5 mol/mol substitution, 
respectively (Fig. 9 and  Table 11). Comparison of the peptide 
maps in Figs. 6 and 9 indicates that the remaining lysine 
residues modified in the presence of NaBH3CN were the same 
residues which  were glycated via the Amadori rearrangement. 
To determine whether the Schiff base was formed at  the a- 
or c-amino group of Lys-1, aliquots of NaBH3CN-reduced 
glycated protein and peptide T1 were hydrolyzed and their 
N"- and N'-glucitollysine content was analyzed by ion ex- 
change HPLC. As shown in Fig. lOA, the  a-amino group of 
Lys-1 was the primary site  (86%) of glycation of this peptide 
isolated from protein at 0.6 mol/mol substitution.  These  data 
indicate that N"-Lys-1 is about  6 times as reactive as N'-Lys- 
1 and more than 10 times  as reactive as  the average t-amino 
group of RNase in forming the Schiff base adduct. The 
presence of 66% of the radioactivity in peptide Tl after 1.5 
mol/mol substitution suggests that  the  a-amino group of the 
protein  had been quantitatively modified by glucose at this 
point. However, analysis of the  total protein at 1.5  mol/mol 
substitution, shown in Fig.  10B,  yielded equal amounts of Nu- 
and N'-glucitollysine. The discrepancy may  be explained in 
part by the unidentified peak at 31 min which  may represent 
a dihexitollysine adduct to Lys-1. 
Overall, the peptide maps obtained in the presence and 
absence of NaBH3CN were qualitatively similar but  quanti- 
tatively distinct. The preferred site of glycation of RNase in 
the presence of NaBH3CN was at Ne-Lys-1,  consistent with 
the low p% of the  a-amino groups. In  contrast,  the preferred 
site of modification of the protein via the Amadori rearrange- 
ment was at Lys-41 in the active site. In addition to Nu-Lys- 
1 and  Ne-Lys-41, the  N-amino groups of lysines 1, 7 ,  and 37 
were also more reactive than other amino groups in either the 
presence or absence of NaBH,CN. 
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FIG. 8. Determination of NO- and N'-hexitollysines in total 
glycated RNase and in peptide TI. A, chromatogram obtained 
from hydrolysate of NaB[3H]4-reduced, glycated RNase. Distribution 
of radioactivity is 17% Nu-  and 83% N'-hexitollysine in total protein. 
B, chromatogram from isolated peptide TI. Distribution is 61% N"- 
and 39% N'-hexitollysine in peptide T1. 0tML = NO-mannitollysine; 
aGL = Nu-glucitollysine; tML = N'-mannitollysine; tGL = N'-gluci- 
tollysine. 
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FIG. 9. Radioactive tryptic peptide map of RNase reacted 
with 6-[SH]glucose in the presence of NaBHsCN. This prepa- 
ration contained 1.5 mol of Glc/mol of protein. The preparation 
containing 0.6 mol of Glc/mol of RNase was essentially identical, 
except for the increased relative intensity of glycated peptide T1. 
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FIG. 10. Determination of Nu- and iV-glucitollysine in 
RNase glycated in the presence of NaBKCN. A, radioactivity 
in glycated peptide T, isolated from RNase containing 0.6 mol of 
Glc/mol of protein. Distribution is 86% Nu-  and 14% Ne-giucitolly- 
sine in peptide TI. B, radioactivity in  total  glycatedprotein containing 
1.5 mol of Glc/mol of RNase. Distribution is 45% N"- and 45% N'- 
glucitollysine. Abbreviations as described in legend to Fig. 8, except 
GL' which is a degradation product formed on hydrolysis of N'- 
glucitollysine (7). 
DISCUSSION 
Glycation is a common post-translational modification of 
proteins in the body. Individual proteins may  be  more or less 
reactive with glucose, but  their  rates  and  extents of glycation 
are dependent on both the ambient glucose concentration  and 
the biological half-life of the protein. Increased glycation and 
subsequent Maillard reactions of glycated proteins have been 
implicated as factors contributing  to pathology in the lens, 
kidney, connective tissue, and vasculature in diabetes (3, 4, 
20, 21). This reaction may also be involved in the normal 
aging of tissues because the  extent of protein glycation in- 
creases with age in man (20), possibly in response to decreased 
protein  turnover and  the development of glucose intolerance. 
Knowledge of the factors affecting the specificity of protein 
glycation may be important in understanding the role of this 
chemical modification in the structural  and functional 
changes in protein which occur both in diabetes and during 
normal aging. 
The work described here began with the observation that 
the inactivation of RNase by  glucose  proceeded  more rapidly 
than the overall rate of glycation of its lysine residues. A 
number of earlier studies  had described the inactivation of 
RNase by chemical modification of lysine residues (8-10) and 
several reagents are known to react preferentially in the active 
site  and to inactivate the enzyme at a  rate much faster than 
the overall rate of lysine modification. This occurs, for ex- 
ample, on dinitrophenylation of RNase (22) or on modifica- 
tion of the enzyme via Schiff base formation with pyridoxal 
phosphate (23). The goal of the present research was to 
characterize the  sites of modification of RNase by glucose and 
to make use of this model protein system to identify factors 
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which might affect the specificity of glycation of other  pro- 
teins. 
Of the 10 lysine residues in RNase,  a  set of 4 (lysines 1, 7, 
37, and 41) has been identified as  preferential  sites of reaction 
with glucose and  Lys-1 was observed to react at both its a- 
and t-amino group. The enhanced reactivity of these four 
lysine residues was apparent in the formation of both Schiff 
base and Amadori adducts to RNase, although the different 
sites varied in their reactivity at  the two steps  in the glycation 
reaction. Adducts of N"- and N'-Lys-1 should be equally 
accessible to reduction by NaBH3CN, but,  consistent with its 
lower  pK,, substantially more  Schiff base is formed at  the a- 
amino group. As shown in Table 11, the initial  distribution of 
Schiff base adducts to RNase (Fig. 9) differs remarkably from 
the eventual  distribution of Amadori adducts (Fig. 6).  Thus, 
not all Schiff bases are equally efficient in undergoing the 
Amadori rearrangement. Comparison of the initial  distribu- 
tion of Schiff base adducts to Lys-1 (a:t = 86:14, Fig. 1OA) 
with the final distribution of Amadori adducts (a:t = 61:39, 
Fig. 8B) indicates that the Amadori rearrangement occurs 
about 4 times faster at  the t-amino group. Similarly, from 
data in Table 11, Lys-41 has  about  13% (9/(0.86 X 82) = 0.13) 
as much Schiff base modification as N"-Lys-1, but  accounts 
for more than twice as much of the Amadori adduct to RNase 
(38/(0.61 X 24) = 2.6). This indicates that  the Schiff base at 
Lys-41 is about 20 times more efficient than  that  at Ne-Lys- 
1 in undergoing the Amadori rearrangement. It is significant 
that  the final  distribution of N'-Lys-41 to  Ne-Lys-1 modifi- 
cation of RNase is not 20:1, but closer to 3:l. Thus,  both  the 
initial  distribution of Schiff base adducts  and the rate of the 
Amadori rearrangement at each site play a role in determining 
the final distribution of Amadori adducts to the protein. 
Similar calculations based on the  data  in Table I1 show that 
Schiff base adducts to Lys-7, which is in the active site  near 
Lys-41, are  about  as reactive as  those at Lys-41 in undergoing 
the Amadori rearrangement. Those at Lys-37 appear to be 
intermediate in reactivity between Ne-Lys-1  and lysines 7 or 
41. The remainder of the amino groups in RNase were not 
particularly reactive in forming either the Schiff base or 
Amadori adduct. The unreactive sites include lysines 31,  61, 
66,91,98,  and 104. The only feature common to these amino 
acids is their location on the surface of the protein, directly 
exposed to solvent. It should be noted that all of these amino 
groups may eventually react with glucose, but that after 
modification of the first five amino groups on RNase the rate 
constant for the glycation reaction declined to  about 20% of 
its original value (7). 
There are several features which distinguish the reactive 
from the unreactive amino groups in RNase. Thus, lysines 1 
and 37 are  adjacent to acidic amino acids, Glu-2 and Asp-38, 
which may be involved in local catalysis of the Amadori 
rearrangement. This is consistent with the observations of 
Shapiro et al. ( 5 )  who noted that a  feature common to several 
lysine residues glycated in hemoglobin was their  nearness to 
carboxylic acid residues in  the primary or three-dimensional 
structure of the protein. Similarly, both lysines 7 and 41 are 
located in the active site cleft of RNase. There is evidence 
that either or both of these  t-amino groups can  participate  in 
the catalytic process (8-lo), although modification of Lys-41 
by bulky reagents generally results in near complete loss of 
enzymatic activity (8, 9, 24, 25). In  our experiments, the 40% 
decrease in activity of RNase containing 1 mol  of Glc/mol of 
protein (Fig. 3) is consistent with the 38% glycation of Lys- 
41 (Table 11). The comparison between glycation of RNase 
and hemoglobin may be extended by noting that the Na- 
amino  termini  are reactive sites for glycation of both  proteins, 
although in hemoglobin the (3-chain terminal valine is much 
more reactive than  the  a-chain valine and also more reactive 
than any lysine residue in the protein (5). It is worth noting 
that  the amino groups most reactive to glycation in RNase 
and hemoglobin, Lysdl  in RNase and (3-Val-1 in hemoglobin, 
share similar environments. Thus,  they  are  both located in 
high affinity binding sites for phosphate ion or organic phos- 
phates, i.e. the binding site for the substrate, RNA, in RNase 
and the binding site for the allosteric effector, 2,3-diphos- 
phoglycerate, in hemoglobin. In both  proteins  these  are rela- 
tively basic regions of the molecule, containing arginine and 
histidine residues in addition to  the reactive amino groups. 
Local catalysis of the Amadori rearrangement of lysines 7  and 
41 in RNase and (3-Val-1 in hemoglobin could be effected by 
either the phosphate ions or histidine residues in these  bind- 
ing sites. This hypothesis would explain the much higher 
reactivity of the @-chain uersus the  a-chain valine residues in 
hemoglobin; despite essentially identical pK, values (24), only 
the reactive (3-terminal valine residue is located in the phos- 
phate binding site. In support of this  interpretation, we have 
observed that  the enhanced reactivity of Lys-41 in RNase, as 
well as  the  rate of inactivation of the enzyme  by  glucose, is 
clearly dependent on the concentration of phosphate ion in 
the incubation buffer.' 
Based on the specificity of glycation of RNase and hemo- 
globin, it seems possible that phosphate binding allosteric or 
active sites of other  proteins may also be preferred sites of 
reaction with glucose. It is of interest that, for proteins studied 
in detail thus far, such as hemoglobin (5, 25, 26), albumin (6, 
27), low density lipoprotein (28-30), and RNase, there  appears 
to be a high degree of specificity in  the reaction of amino 
groups with glucose. Thus, glycation of relatively few amino 
groups in these proteins seems to have pronounced effects on 
their allosteric sensitivity (25), ligand binding (26, 27), recep- 
tor recognition (28-30), and enzymatic activity (this work), 
respectively. Although glycation of protein is a slow reaction, 
it is tempting to remark that glucose has some of the  char- 
acteristics of a site-specific reagent for enzymes and proteins. 
The increased glycation of protein in diabetes, coupled with 
the specificity of this reaction, suggests that  further study of 
protein glycation in diabetes will  be important for understand- 
ing the metabolic and  structural consequences of hypergly- 
cemia. 
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